Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
Home Office squandered billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
Home Office squandered billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.